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Abstract
Caspases are the key players of apoptosis and inflammation. They are present in the cells as latent
precursors, procaspases, and are activated upon an apoptotic or inflammatory stimulus. The activation
mechanism of caspases has been studied extensively by biochemical and biophysical methods.
Additional structural information on active caspases with a variety of different inhibitors bound at the
active site is available. In this study, we investigated the cleavage mechanism of caspase-8 from its
zymogen to active caspase-8 by solution NMR and by biochemical methods. The intermolecular
cleavage reaction using the catalytically inactive C285A procaspase-8 mutant is triggered by adding
caspase-8 and followed by 15N,1H-NMR spectroscopy. The spectrum that initially resembles the one of
procaspase-8 gradually over time changes to that of caspase-8, and disappearing peaks display
exponential decaying intensities. Removal of either one of the cleavage recognition motifs in the linker,
or phosphorylation at Tyr380, is shown to reduce the rate of the cleavage reaction. The data suggest that
dimerization repositions the linker to become suitable for intermolecular processing by the associated
protomer. Furthermore, analysis of inhibitor binding to the active caspase-8 reveals an induced-fit
mechanism for substrate binding.
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ABSTRACT  
Caspases are the key players of apoptosis and inflammation. They are present in the cells as 
latent precursors, procaspases, and are activated upon an apoptotic or inflammatory stimulus. 
The activation mechanism of caspases has been extensively studied by biochemical and 
biophysical methods. Additional structural information on active caspases with a variety of 
different inhibitors bound in the active site is available. In this study we investigated the 
cleavage mechanism of caspase-8 from its zymogen to active caspase-8 via solution NMR 
and by biochemical methods. The intermolecular cleavage reaction using the catalytically 
inactive C285A procaspase-8 mutant is triggered by adding caspase-8 and followed by 
15N,1H-NMR spectroscopy. The spectrum that initially resembles the one of procaspase-8 
gradually over time changes to the one of caspase-8, and disappearing peaks display 
exponential decaying intensities. Removal of either one of the cleavage recognition motifs in 
the linker or phosphorylation at Tyr380 is shown to reduce the rate of the cleavage reaction.  
The data suggest that dimerization repositions the linker to become suitable for 
intermolecular processing by the associated protomer. Furthermore, analysis of inhibitor 
binding to the active caspase-8 reveals an induced fit mechanism for substrate binding.  
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ABBREVIATIONS:  EDTA, Ethylenediaminetetraacetic acid; LDAO, Lauryldimethylamine-
oxide; GdHCl,  Guanidine hydrochloride; DTT,  Dithiothreitol; HSQC, Heteronuclear single 
quantum coherence; TROSY, Transverse relaxation optimized spectroscopy; TCEP, Tris(2-
carboxyethyl)phosphine; ATP, Adenosintriphosphat; AMC, 7-amino-4-methylcoumarin; 
cmk, chloro-methylketone 
INTRODUCTION 
Caspases are cysteine-dependent enzymes with specificity for aspartic acid in the cleavage 
recognition motif of their substrates and are involved in apoptosis and inflammation (1-4). In 
apoptosis, initiator caspases are the most apical enzymes, which receive the apoptotic signal 
and activate downstream executioner caspases. Initially, caspases are produced in the cells as 
inactive zymogens, the procaspases (1-3, 5). Inflammatory and apoptotic initiator procaspases 
are monomeric and contain an N-terminal prodomain that facilitates their recruitment to 
macromolecular activation platforms such as the death inducing signaling complex (DISC) 
(6, 7), the apoptosome (8, 9), the PIDDosome (10, 11) or the inflammasome (12). Through 
binding to these complexes their apparent concentration is increased and dimerization is 
induced. Dimerization then triggers activation of the initiator caspases as proposed by the 
induced proximity model (13, 14). While forced into mutual proximity at the activation 
complexes, autoproteolytic cleavage of the intersubunit linker occurs. A second cleavage 
event between the prodomain and the catalytic domain releases the active caspase from the 
activation complex (15). For executioner caspases cleavage of the intersubunit linker 
constitutes the major event for activation while for initiator caspases it is dimerization (16). 
Fundamental insight into the mechanism of caspase activation has been derived from crystal 
structures, with most of the structures of active caspases determined in the presence of 
inhibitors (17). Additional crystal structures of inflammatory caspase-1 and executioner 
caspase-7 in the absence of inhibitors report on structural changes upon inhibitor binding, 
suggesting an induced fit mechanism of substrate binding (18, 19). Furthermore, a few 
zymogen structures are available, e.g. for Drosophila melanogaster Dronc (20), for 
executioner procaspase-7 (18), for inflammatory procaspase-1 (21) and for procaspase-8 (22). 
The latter was solved by solution NMR and for the first time revealed the position of the 
intersubunit linker in a monomeric zymogen. 
Caspase-8 is one of the best-studied initiator caspases. The recently determined solution 
structure of procaspase-8 and the available crystal structures of caspase-8 in the presence of 
various inhibitors provide important information to decipher the activation mechanism of 
caspase-8 (22-25). Additional mutational studies dissected the interplay between dimerization 
and proteolytic cleavage (13-15, 22, 26-28). Although dimerization is required and by itself 
sufficient for caspase-8 activity, cleavage of the intersubunit linker at two different 
recognition motifs is important for dimer stabilization and thus is essential for caspase-8 
activity (22). While the importance of dimerization and cleavage is established experiments 
that describe the transition from the inactive zymogen to the activated and to the inhibitor-
bound caspase-8, are not available presently. Furthermore, to our knowledge a structure of 
caspase-8 in the absence of an inhibitor has not yet been published. In this work we 
interrogate the activation mechanism from monomeric, unprocessed zymogen to processed, 
dimeric caspase in the absence of inhibitors using solution NMR as the primary tool. We 
follow the cleavage reaction in the NMR tube by monitoring procaspase-8 processing using 
15N,1H correlation NMR spectroscopy. In addition, we determine to which extent the 
efficiency of caspase-8 processing is influenced by the dimerization propensity, by 
phosphorylation at Tyr380 and by limited proteolysis of the intersubunit linker. Finally, 
NMR data are used to evaluate how the structure of the free caspase-8 differs from the 
inhibitor-bound form. 
RESULTS  
 
Processing of procaspase-8 into active caspase-8 
To characterize the events leading to activation of caspase-8 on a molecular level we 
followed the cleavage process from procaspase-8 to active caspase-8 by NMR. 15N-labelled 
procaspase was mixed with catalytic amounts (1:10000) of unlabelled caspase-8. Processing 
of procaspase-8 by caspase-8 was monitored by recording [15N, 1H]-TROSY spectra. Since 
only procaspase-8 is labeled, initially the spectrum resembled the one of procaspase-8, for 
which an assignment was obtained previously (22) and gradually over time changed into the 
spectrum corresponding to caspase-8. At the beginning of the experiment the narrower lines 
of procaspase-8 allowed recording spectra in 1 hour intervals. During biochemical processing 
a decrease of the signal intensity in the spectra occurred for most resonances reflecting the 
formation of dimeric caspase-8 accompanied by slight precipitation. Significant line-
broadening is observed for the methyl resonances (Figure 1B) correlating well with increased 
processing as independently monitored by SDS PAGE (Figure 1A).  
While most of the peaks remained unchanged a significant number of peaks decreased in 
intensity, and new peaks appeared (Supplementary Figure S1). A few very strong peaks 
appeared in the random coil region. Since these signals were absent in spectra of the 
separately produced caspase-8, in which the intersubunit fragment was removed during 
purification, they most likely correspond to the fragment excised during cleavage.  
Comparing peak integrals over time we observed an exponential decay of all peaks (Figure 
1C). After approximately 30 hours the peaks in the [15N, 1H]-TROSY spectra contain about 
30 % of their original intensity. An example is depicted in Figure 1C, were signals from the 
C-terminus, which is identical in procaspase-8 and caspase-8, are presented. In contrast, 
signal intensity for all regions affected by processing is below 5% of their initial values. 
Unfortunately, the time resolution is insufficient to allow distinguishing whether events occur 
simultaneously or in sequential order.  
 
Caspase-8 undergoes structural changes during processing and during inhibitor binding. 
Processing of procaspase-8 into caspase-8 is accompanied by large spectral changes that are 
difficult to interpret. Furthermore, during the long measurement time protein precipitated 
resulting in a decrease in protein concentration leading to a reduction in signal intensity. 
Therefore, we decided to characterize the product of the cleavage reaction in its purified 
form. Accordingly, caspase-8 was prepared from the active wild-type procaspase-8 in 15N,2H-
labelled form. The similarity of [15N, 1H]-HSQC and [15N, 1H]-TROSY spectra recorded on 
the cleavage-incompetent C285A procaspase-8 mutant and caspase-8 indicates that both 
proteins are structurally highly similar (Figure 2A). Only signals corresponding to the loops 
and the linker as well as from residues of the β-strands 5 and 6, which in procaspase-8 are in 
close proximity to the intact linker, were significantly shifted in position. In addition, β-
strand 6 forms the dimerization interface in active caspase-8, and therefore residues from 
these strands are expected to experience chemical shift changes.  
During processing, the oligomerization state of the enzyme changes (Table 1). At the 
approximate concentration used in the NMR experiments procaspase-8 is purely monomeric 
whereas caspase-8, that is known to exist in a concentration-dependent monomer/dimer 
equilibrium (22, 27), is present as a dimer at 81%. The increasing population of dimeric 
states during caspase-8 activation is also apparent from the line-widths of methyl signals in 
proton spectra (Figure 2B). In addition, the peaks are shifted in position indicating that they 
belong to residues undergoing structural changes or become involved in forming 
intermolecular contacts.  
Structural information is available for procaspase-8 and inhibitor-bound caspase-8 but not for 
the inhibitor-free enzyme. The above-described data allows comparing caspase-8 in its 
zymogen and in the inhibitor-free state. In order to assess how the free enzyme differs from 
the published inhibitor-bound crystal structure we added the irreversible Ac-DEVD-cmk 
inhibitor and monitored changes by chemical shift mapping. Interestingly, significant 
changes in peak positions occur. Analysis of the crystal structure of DEVD bound to caspase-
8 reveals that about 21 amino acids are either directly involved in inhibitor binding or are in 
close vicinity. Surprisingly, comparison of the [15N, 1H]-TROSY spectra of caspase-8 in 
presence and absence of the inhibitor reveals that more than 70 peaks are shifted, suggesting 
further structural changes to take place upon inhibitor binding. Considering that the majority 
of the secondary structure elements are identical it is likely that these peaks belong to the 
active site forming loops or be located at the dimerization interface. However, the population 
of the dimer in presence vs. absence of inhibitor as determined by analytical 
ultracentrifugation is 81% and 89% (Table 1), respectively, and hence the difference is too 
small to explain the changes observed in the spectra. Moreover, a number of new peaks 
appear with rather strong intensity that must belong to residues in more flexible regions such 
as the active site forming loops.  
To access the influence of activation and inhibitor binding on the overall protein stability the 
melting points of the proteins were determined by CD spectroscopy (Figure 2C). 
Dimerization and cleavage of the zymogen results in improved protein stability characterized 
by a 6.6 degree increase in the melting temperature for caspase-8 compared to procaspase-8. 
This effect highlights the contribution of intermolecular contacts from residues of the cleaved 
linker and at the terminal beta strand to protein stability and provides a rationale for the 
driving force for cleavage and dimerization. An even more pronounced stabilizing effect was 
observed upon covalent inhibitor binding to caspase-8, which elevates the melting 
temperature by approximately 20 degrees.  
 
Determinants of the processing rate of procaspase-8 
In the following we analyze to which extent the rate of processing of procaspase-8 by the 
addition of catalytic amounts of the active enzyme is influenced by the propensity for 
dimerization, by phosphorylation of procaspase-8 and by insufficient cleavage of the 
intersubunit linker. Therefore, we mutated either one of the Asp cleavage motifs in the linker, 
introduced a mutation at the dimerization interface or phosphorylated procaspase-8 in vitro 
(Figure 3). In order to prevent self-activation the constructs harbor an additional C285A 
mutation. To all mutants active caspase-8 was added in catalytic amounts (1:1000), the 
reaction was stopped at indicated time points, and the rate of processing was analyzed by 
SDS PAGE and densitometry. Over time the intensity of the bands corresponding to full-
length protein decreased and new bands for p18/p19 and p11/p12 subunits became visible. 
Integration of the bands corresponding to full-length protein revealed a double-exponential 
decay (Figure 4A). While the procaspase-8 mutants are rapidly processed in the beginning of 
the experiment cleavage rates are reduced later on. We believed this to be mainly due to a 
decrease in enzymatic activity of caspase-8 over time and therefore determined the activity of 
caspase-8 using the fluorogenic Ac-DEVD-AMC substrate. After 3000 minutes caspase-8 
retains 1% of its original activity (Figure 4B). The same experiment was performed by 
further addition of 1000 equivalents of the procaspase-8 mutant C285A-DDAA that cannot 
be cleaved due to the double mutation D374A D384A (DDAA) and also cannot process other 
substrates. This mutant does not compete with the Ac-DEVD-AMC substrate for the active 
site of caspase-8 in contrast to procaspase-8. Surprisingly, addition of C285A-DDAA 
resulted in increased caspase-8 activity (Figure 4C) and retarded caspase-8 deactivation 
(Figure 4B) indicating that it is able to interact with caspase-8, most likely via 
heterodimerization. Furthermore, analytical ultracentrifugation revealed that the affinity for 
dimer formation in cleaved procaspase-8 is only slightly lower than for caspase-8 (Table1).  
Despite the time dependent deactivation of caspase-8, a comparison of the cleavage 
efficiencies for the various substrates can still be made because all cleavage reactions have 
been performed under identical conditions and hence deactivation of caspase-8 and therefore 
remaining active caspase-8 is comparable in all samples at identical time points. 
Interestingly, all the analyzed mutants are less efficient in processing when compared to 
procaspase-8. While initial processing rates are similar within the range of the experimental 
error pronounced differences are observed after approx. 5-10 hours. In case of the Asp 
mutants the processing rate is more strongly affected for D384A. Analytical 
ultracentrifugation data of the cleavage products of both mutants reveals that the affinity for 
dimerzation is impaired compared to cleaved procaspase-8, and that this reduction is larger 
for D384A than for D374A. Moreover, F468A shows a significant decrease in the processing 
rate as compared to procaspase-8 underlining the important role of dimerization for 
activation.  
Previous studies by Cursi et al. revealed a negative effect on Fas-induced apoptosis after  
phosphorylation of caspase-8 by Src kinase (29). Src kinase phosphorylates caspase-8 
specifically at Tyr380, which is located between the two cleavage recognition motifs within 
the linker and is excised during processing. In this study, we phosphorylated caspase-8 in 
vitro with Src kinase. Phosphorylation of caspase-8 was detected by Western blot using a 
specific phospho-tyrosine antibody (Figure 4D). The rate of conversion for phosphorylated 
procaspase-8 is slower than for its unphosphorylated counterpart (Figure 4A). Interestingly, 
the band observed on SDS PAGE decreases faster in intensity than the band on the western 
blot, indicating that the unphosphorylated enzyme is preferably cleaved (Figure 4D). 
Phosphorylation at Tyr380 can reduce the rate of processing and thus caspase-8 activation 
and apoptosis by either sterically blocking access to the cleavage sites or by altering the 
conformation of the linker.  
DISCUSSION  
Activation of inflammatory and apoptotic initiator procaspases proceeds through 
dimerization, which is stabilized by subsequent proteolytic processing. And although our 
understanding of the underlying molecular processes has greatly advanced with the 
development of important concepts like the induced-proximity model (13, 14) the exact 
molecular details are still not fully understood. Only a few procaspase structures are available 
such as for Drosophila melanogaster Dronc (20), procaspase-7 (18), procaspase-1 (21) and 
procaspase-8 (22). Much more structural information is available on active caspases in 
presence of bound inhibitors whereas currently no structural information is available for 
inhibitor-free apoptotic initiator caspases. In contrast structures describing the dimers of 
caspase-1 and -7 have been published in both the inhibitor free and inhibitor-bound states 
(18, 19). 
In this work we investigated cleavage of procaspase-8 and subsequent binding of substrates 
applying chemical shift mapping and biochemical methods. In the conducted experiments 
trace amounts of active caspase-8 triggered conversion of procaspase-8 mutants that are 
deficient of autoprocessing. Previous studies on procaspase-8 and caspase-8 stated that 
caspase-8 has no specificity for its own zymogen (15). The experiments presented in this 
work, however, clearly demonstrate processing of the zymogen after addition of caspase-8 
indicating that caspase-8 does have specificity for procaspase-8.  
Cleavage of procaspase-8 results in an apparent increase in molecular weight and large 
structural differences in the loops and at the dimerization interface. In principle, cleavage can 
be accomplished in three different ways: i) by an intramolecular process, ii) by an 
intermolecular process in which the participating Asp and Cys residues are part of different 
protomers within the same dimer (intradimeric) or iii) by an intermolecular process involving 
a proximal caspase dimer (interdimeric). All constructs that were tested for cleavage 
contained the active site C285A mutation and are incapable of self-processing and therefore 
require intermolecular cleavage. The observation that an inactive, cleavage-incompetent 
C285A-DDAA mutant increases the activity of caspase-8 suggests that heterodimerization 
between procaspase-8 and caspase-8 occurs. Considering the vast excess of the procapase-8 
mutants over active capase-8 (1000:1 in the biochemical and 10000:1 in the NMR 
experiments) caspase-8 is more likely to associate with procaspase-8 than with itself, which 
supports the intra-dimeric cleavage hypothesis. In addition, the concentration of caspase-8 
was in the nanomolar range where caspase-8 homodimer formation (Kd of ~ 50 µM (27)) is 
unlikely, whereas our assay concentration of procaspase-8 (250 µM) was well above this 
threshold. While the affinity of caspase-8 for procaspase-8 may be lower than for caspase-8 
formation of the heterodimer could result in immediate processing. Finally, intra-dimeric 
attack by Cys285 is expected to be favored kinetically. Our in vitro experiments support this 
view since they reveal a correlation between dimerization and cleavage of the substrate. 
Processing is slowed down in the dimerization-incompetent F468A mutant. Although F468A 
is incompetent for homo-dimerization because cross-strand intermolecular interactions of 
Phe468 with Pro466 have been removed, due to the pseudo-symmetry in the heterodimer one 
of the two Pro-Phe contacts remain. We expect the Kd for formation of the heterodimer to be 
lower than the corresponding value for formation of the homodimer in caspase-8, and this is 
reflected in the reduced processing rate. The connection between the rate of processing and 
the affinity for dimerization for the cleaved enzyme might also explain the reduced 
processing rates for the cleavage mutants D374A and D384A. Both mutants display a 
reduction in dimerization affinity, which is more pronounced in the slower processing D384A 
mutant. 
If such intra-dimeric attack takes place the linker must undergo a dramatic conformational 
change in order to bring Asp374 and Asp384 into proximity of the catalytic Cys285 from the 
other protomer. One plausible scenario is that the relocation of the linker is triggered by 
dimerization that pushes loop 4 and possibly loop 5 towards that active site thereby 
displacing the linker segment from that region. We noticed that resonances from loops 4 and 
5 were completely absent in the 15N,1H-correlation spectra of procaspase-8, indicating that 
these two loops interconvert between at least two different states, and hence intrinsically 
sample a larger conformational space (22).  
The proposed conformational change is very large but precedence for such a linker topology 
is found in the crystal structure of procaspase-1. Although procaspase-1 is monomeric in 
solution it was crystallized as a dimer with the linker located in a cleft at the dimer interface 
and the cleavage motif for the first processing site positioned close to the active site of the 
second protomer (Figure 5C, (21)). Furthermore, the linker in procaspase-1 is similarly 
positioned as the cleaved linker of active caspase-1 and -8 (Figure 5A). Loops 3 and 4 
(corresponding to loops 4 and 5 in procaspase-8) are slightly shifted towards the active site 
supporting their role in linker displacement. Thus the structure of the procaspase-1 displays 
all structural elements that are required for the proposed mode of cleavage for procapase-8 
and we have taken this as a model of how the structure of procaspase-8 could change during 
dimerization. 
Previous studies state that dimerization is the prime event in initiator caspase activation that 
triggers structural rearrangements of the active site forming loops leading to formation of the 
active site (14, 22, 27, 28, 30, 31). Our chemical shift mapping experiment using the DEVD 
inhibitor indicates that dimerization is not sufficient to form a proper active site, and that 
additional significant changes occur upon inhibitor binding. This statement is supported by 
similar conclusions drawn from the comparison of crystal structures of caspase-1 and 
caspase-7 in presence or absence of inhibitors and their corresponding zymogens (18, 19). In 
both enzymes structural differences are observed in the active site forming loops 3 and 4 and 
in the linker fragments with the inhibitor-free form being a structural intermediate between 
the zymogen and the inhibitor-bound species (Figure 5B). Moreover, loops 3 and 4 are 
arranged in a way that the substrate-binding pocket is not properly formed in the absence of 
inhibitors. Furthermore, the cleaved linker fragments L2 and L2’ of the associated protomers 
interact with each other in all inhibitor-bound crystal structures while they are separated in 
inhibitor-free caspase-7 (18). Mutants of caspase-8 in which the L2 loop is truncated 
experience a significant shift towards the monomeric state for caspase-8 suggesting their 
importance for dimer stabilization (22). Structural differences of the L2 loop between 
inhibitor-free and inhibitor-bound caspase-8 could explain the higher dimer affinity upon 
inhibitor binding, a common phenomenon for initiator caspases (27).  
Previous experiments on caspase-7 revealed an increased overall protein stability upon 
inhibitor binding by 17.9 degrees (32), which is in the same range as observed for caspase-8 
and in case of dimeric caspase-7 must be independent of dimerization. We therefore 
speculate that the increased overall stability of caspase-8 upon addition of the inhibitor is due 
to rigidification of the loops around the active site and possibly may also involve loop 4 and 
5, which in procaspase-8 undergo conformational exchange (22). 
Structures for inhibitor-free caspases have also been determined for caspase-3 (33,34) and -9 
(31). Caspase-9 belongs to the initiator caspases, and the proenzyme is monomeric, indicating 
that the mechanism of action might be highly similar to the one of caspase-8. The crystal 
structure of dimeric caspase-9 however, revealed that only one active site within the dimer is 
occupied by the inhibitor, whereas the unbound protomer reveals a different conformation 
with characteristics of the proform (31). Obviously, the inhibitor-bound species of caspase-9 
is different than for caspase-8, and therefore a comparison of the mechanisms is difficult on 
the basis of the presently available data. Rearrangements upon inhibitor binding in the 
executioner caspase-3 are limited to side chains of 3 hydrophobic residues lining the S2 
pocket and no loop stabilization was observed (33, 34) in contrast to the more extensive 
changes in capase-8. In how far the unbound structure of caspase-3 differs from the zymogen 
cannot be assessed since no structural information on the proform is available. 
These observations together with our data suggest that substrate binding to the active site 
pocket during caspase activation probably generally occurs via an induced-fit mechanism. 
Whether the changes in caspase-8 involve larger conformational changes of the loops as 
observed for caspase-1 and -7 or minor side chain rearrangements as seen in caspase-3 cannot 
be distinguished based on our experiments. However, the data confirm that dimerization is 
the prime event during caspase-8 activation and allow expanding the current model of 
initiator caspase activation (Figure 6). We propose that dimerization helps relocating the 
cleavage motifs within the linker to become accessible for intermolecular cleavage and 
initiates prebuilding of the active site, which finally forms upon substrate binding. 
Caspase-8 activation at the DISC is a very complex issue that is difficult to address in vitro 
and certainly requires additional biochemical experiments under conditions that better mimic 
the DISC environment. The model for caspase-8 activation proposed in this work provides a 
working hypothesis that may help guiding the design of such experiments.  
MATERIALS AND METHODS 
 
Protein design, expression and purification:  
The DNA sequence coding for human caspase-8 amino acids 217-479 was cloned into a 
pQE50 vector (Qiagen). Amino acid substitutions were generated by Quikchange® 
(Stratagene) mutagenesis. The plasmids were transformed into M15 (pREP4) cells (Qiagen), 
and the protein was expressed at 37ºC overnight either in LB (unlabeled protein) or in M9 
(15N-labeled protein) medium. M9 minimal media was supplemented with 15NHCl4 as the 
sole nitrogen source. Deuteration was achieved by growing cells in D2O. 
The purification protocol was adapted from published procedures (25) and was described 
previously (22). Cells were harvested, resuspended in PBS buffer and lyzed by french press. 
The soluble protein fraction was removed by centrifugation, inclusion bodies washed in 20 
mM Tris pH 8.0, 1 mM EDTA, 0.1% LDAO and solubilized in 6.5 mM GdHCl, 20 mM Tris 
pH 8.0, 2 mM EDTA, 100 mM DTT. The solubilized inclusion bodies were added to an 
equal volume of acetic acid and the sample dialyzed against 50% acetic acid. Subsequently 
the solution was suspended rapidly in nine volumes H2O and immediately diluted in nine-fold 
excess of 1 M Tris pH 8.0, 5 mM DTT. Refolding was performed over night at room 
temperature and aggregates were removed by centrifugation. Final purification was achieved 
by size exclusion chromatography on a Superdex 200 column (Amersham) using 20 mM 
Tris, pH 8.0, 100 mM NaCl, 10% sucrose, 0.5 mM TCEP. In this buffer the protein can be 
stored at -80ºC. Light-scattering was used to confirm monodispersity of the refolded purified 
sample. 
 
NMR experiments: 
NMR samples were rebuffered into 20 mM deuterated Tris pH 8.0, 100 mM KCl, 10 mM 
DTT. Procaspase-8 that was used to monitor the time-course of cleavage and active caspase-8 
was both 2H,15N-labelled. The irreversible tetrapeptidic AC-DEVD-cmk inhibitor was added 
in five-fold excess to 2H,15N-labelled active caspase-8. All NMR experiments were recorded 
at 305 K on a Bruker Avance 700 MHz spectrometer, equipped with a triple-resonance 
cryoprobe. [15N, 1H]-HSQC and [15N, 1H]-TROSY experiments were recorded during 
cleavage for monomeric proteins and of dimeric caspase-8, respectively. The spectra were 
processed in Topspin2.1 (Bruker) and transferred to CARA for spectral analysis (35). 
Complete processing at both cleavage sites was confirmed by MALDI mass spectroscopy. 
 
Analytical Ultracentrifugation: 
Analytical ultracentrifugation was performed with an Optima XL-1 centrifuge (Beckman 
Coulter) and a TI50 rotor using epoxy centerpieces (12 mm) with sapphire windows. Samples 
were run at 20ºC and 42000 rpm. Absorption was measured between 280 and 315 nm, 
depending on protein concentration. Results were analyzed using Sedfit (36). 
 
CD Spectroscopy 
Thermal denaturation was performed on a Jasco J-715 spectropolarimeter equipped with a 
temperature control unit. The concentrations of the samples were 100 µM using a quartz 
cuvette with a 1 mm path length. Data points were taken at 222 nm while increasing the 
temperature by 1°C/min from 5°C to 95°C. The band-width was set to 1 nm and the response 
time to 4 s. 
 
 
In vitro cleavage experiments: 
All proteins were dialyzed against phosphorylation buffer (50 mM Tris pH 8.0, 150 mM 
NaCl, 0.5 mM TCEP, 20 mM MgCl2, 12.5 mM MnCl2, 12.5 mM β-glycerolphosphate). 
Phosphorylation of procaspase-8 was accomplished by incubation with Src kinase 
(SignalChem) with 25-fold excess of procaspase and 5 fold excess of ATP at 37ºC for 3 hrs. 
Small amounts of precipitated protein were removed by centrifugation. The final sample 
volume for monitoring the cleavage reaction was 200 µl containing 250 µM procaspase-8 
mutants. The reaction was started by addition of 250 nM caspase-8. Small aliquots were 
removed at indicated time points, immediately suspended in hot 5x SDS loading buffer and 
incubated for 5 min at 95ºC. The cleavage educts and products were separated by SDS 
PAGE. The gels were scanned in a Fuji LAS 3000 image reader (FujiFilm) and the bands 
corresponding to full-length caspase-8 analyzed by densitometry using the AIDA image 
analyzer software. The obtained values were normalized by setting the concentration of full-
length protein at the beginning of the reaction to 100% and by appropriate scaling of all 
subsequent data. Measurements were performed in triplicate and the standard deviations were 
calculated. Initially we tried to fit the kinetic data against single-exponentially decaying 
functions but discovered that data could not be fit well due to inactivation of caspase-8. 
Inactivation of caspase-8 in the absence and presence of PC8 DDAA was determined by 
addition of the Ac-DEVD-AMC substrate at a final concentration of 100 µM. The 
concentrations of the proteins and the buffer were the same as used in the cleavage reactions 
described above. Measurements were performed in triplicate in black 96-well Nuncion 
microtiter plates using the Magellan6 software on a GENios plate reader (Tecan). AMC 
release was monitored by its fluorescence at 465 nm following excitation at 360 nm.  
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TABLE AND FIGURE LEGENDS 
 
Table 1: Data derived from analytical ultracentrifugation of constructs used for the NMR and 
the cleavage experiments. Samples were measured at concentrations of 800 µM and 250 µM 
for NMR and cleavage experiments, respectively. Constructs used for the cleavage 
experiments harbor the active site mutation C285A and were processed by caspase-8 addition 
at a 1:1000 ratio. *The value in brackets was obtained previously at the same concentration 
for active caspase-8 which underwent autoproteolytic processing (22). 
 
Figure 1: Processing of procaspase-8 into caspase-8. Labeled procaspase-8 was incubated in 
a 1:10.000 ratio with unlabelled caspase-8. Cleavage was monitored simultaneously by SDS 
PAGE and NMR.  
A) SDS PAGE with procaspase-8 samples obtained at indicated time points during the 
cleavage process.  
B) Regions of 1D proton spectra displaying the methyl region recorded at indicated time 
points.  
C) Time course of signal decrease in [15N, 1H]-TROSY spectra. Peak intensities present 
averages for all residues from the segment indicated on the plots. Error bars reflect the 
standard deviation from the mean. 
 
Figure 2: Comparison of procaspase-8 (black) with caspase-8 in the absence (blue) and 
presence (red) of the tetrapeptidic DEVD inhibitor. 
A) Overlay of a [15N, 1H]-HSQC spectrum with [15N, 1H]-TROSY spectra of caspase-8 in the 
absence or presence of the Ac-DEVD-cmk inhibitor. Differences in peak positions indicate 
changes in the environment of the corresponding amide moieties due to conformational 
changes or contacts to the inhibitor.  
B) Section of the high-field region of a 1D proton spectrum displaying methyl signals. Line-
widths are correlated with protein size such that increasing molecular weight during 
dimerization results in broader lines. Furthermore, differences in peak positions were 
observed as also seen in A). 
C) Thermal denaturation of procaspase-8 and caspase-8 before and after inhibitor binding 
followed by CD spectroscopy. CD signals recorded at 222 nm were used to calculate the 
fraction of folded protein. The melting temperatures for the individual proteins are indicated 
in the plot.  
 
Figure 3: Overview of caspase-8 mutants used in this study indicating positions of individual 
mutation sites. 
 
Figure 4: Processing of various procaspase-8 mutants by caspase-8.  
A) Time course of processing for various mutants (see panel) of procaspase-8 displaying the 
percentage of unprocessed protein at indicated time points. Processing was determined by 
SDS PAGE and densitomety on bands corresponding to uncleaved enzyme.  
B) Time-dependent deactivation of caspase-8 in the absence and presence of the inactive 
uncleavable C285A-DDAA mutant monitored by conversion of the fluorogenic Ac-DEVD-
AMC substrate.  
C) Influence of inactive uncleavable procaspase-8 C285A-DDAA on caspase-8 activity.  
D) SDS PAGE and corresponding Western blot of phosphorylated procaspase-8 following 
addition of caspase-8. 
 
Figure 5: Comparison of different caspase activation states.  
A) Superposition of procaspase-1 (blue, pdb code 3E4C) and caspase-1 in the absence (green, 
pdb code 1SC1) and presence (red, pdb code 1IBC) of a tetrapeptidic WEHD inhibitor 
(yellow).  The active site forming loops are labeled and indicated in bright colors. The 
tetrapeptidic inhibitor is presented as sticks.  
B) Superposition of procaspase-7 (pdb code 1K88) and caspase-7 in the absence (pdb code 
1K86) and presence (pdb code 1F1J) of a tetrapeptidic DEVD inhibitor. The color coding and 
labeling is the same as described in A).  
C) Comparison of the linker orientation in dimeric procaspase-1 (brown) and monomeric 
procaspase-8 (blue, pdb code 2K7Z). The active site cysteine and the Asp residues in the 
cleavage motifs are presented as sticks. All figures were prepared using PyMol (37). 
 
Figure 6: Schematic drawing of the caspase-8 activation mechanism. The large and small 
subunits are indicated by large and small boxes, respectively. The active site forming loops 
and the linker are depicted as lines and labeled according to the nomenclature used in Keller 
et al. 2009 (22).  
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